Extracellular Vesicles as Novel Diagnostic and Therapeutic Agents for Non-Melanoma Skin Cancer: A Systematic Review
Open Access
- 23 February 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (5) , 2617
Abstract
Standard non-melanoma skin cancer (NMSC) treatment involves surgery, recently combined with chemotherapy or immunotherapy in cases of advanced tumors. EVs, including exosomes, are integral to carcinogenesis, and are found in NMSC releasing mediators impacting tumor progression. Nevertheless, the precise intercellular signaling role of NMSC-derived EVs remains unclear. This review aims to elucidate their potential role in NMSC diagnosis and treatment. This systematic review encompassed literature searches in electronic databases from inception to September 2023, based on certain inclusion and exclusion criteria, addressing NMSC-derived EVs, their molecular cargo, and their implications in the diagnosis, prognosis, and treatment of NMSC. Key components were identified. Extracellular vesicle (EV) proteins and RNA have emerged as diagnostic biomarkers in EV-based liquid biopsy. Circular RNA CYP24A1, known for its molecular stability, holds promise as a diagnostic biomarker. Long noncoding RNAs (lincRNA-PICSAR) and Desmoglein 2 (DSg2) are linked to drug resistance, serving as prognostic biomarkers. EV mediators are being actively investigated for their potential role as drug delivery agents. In conclusion, this systematic review showed that NMSC-derived EVs display promise as therapeutic targets and diagnostic biomarkers. Further research is imperative to fully comprehend EV mechanisms and explore their potential in cancer diagnosis and treatment.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- Reproducibility of extracellular vesicle researchEuropean Journal of Cell Biology, 2022
- Exosomes as Carriers for Drug Delivery in Cancer TherapyPharmaceutical Research, 2022
- Tumor-derived exosomes: the emerging orchestrators in melanomaBiomedicine & Pharmacotherapy, 2022
- New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell CarcinomaAdvances in Therapy, 2022
- Immunotherapy for Non-melanoma Skin CancerCurrent Oncology Reports, 2021
- European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and preventionEuropean Journal of Cancer, 2020
- Extracellular vesicles as drug delivery systems: Why and how?Advanced Drug Delivery Reviews, 2020
- Extracellular Vesicles as Biomarkers for the Detection of a Tumor Marker Gene in Epidermolysis Bullosa-Associated Squamous Cell CarcinomaJournal of Investigative Dermatology, 2018
- Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayersCancer Letters, 2017
- Different exosome cargo from plasma/bronchoalveolar lavage in non‐small‐cell lung cancerGenes, Chromosomes and Cancer, 2014